Home » Topics » Disease categories and therapies » Immune

Immune
RSS

CytRx and Merck enter TranzFect agreement

Nov. 16, 2000

Licensing opportunity from NIH: subunit vaccine for viral diseases

Nov. 16, 2000

FK-3311 reduces ischemia/reperfusion injury to the lung in rat model

Nov. 15, 2000

Galenica and U.S. Navy to evaluate malaria vaccine adjuvant

Nov. 15, 2000

Encouraging preclinical data reported for BioSante's CAP vaccine adjuvant

Nov. 15, 2000

Novel immunomodulators claimed by Abbott in patent literature

Nov. 8, 2000

CPMP issues positive opinion for Prevenar

Nov. 8, 2000

Siga and Maxygen collaborate on development of novel vaccines

Nov. 6, 2000

Novel inhibitors of IMPDH synthesized and tested for biological activity at Vertex

Nov. 3, 2000

CpG-7909 is a safe and effective adjuvant to HBV vaccine, according to early phase I results

Nov. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...